Kadayat Tara Man, Park Chanmi, Jun Kyu-Yeon, Thapa Magar Til Bahadur, Bist Ganesh, Yoo Han Young, Kwon Youngjoo, Lee Eung-Seok
College of Pharmacy, Yeungnam University, Gyeongsan 712-749, Republic of Korea.
College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Global Top 5 Program, Ewha Womans University, Seoul 120-750, Republic of Korea.
Eur J Med Chem. 2015 Jan 27;90:302-14. doi: 10.1016/j.ejmech.2014.11.046. Epub 2014 Nov 24.
For the development of novel anticancer agents, we designed and synthesized hydroxylated 2,4-diphenyl indenopyridines, and evaluated their topoisomerase inhibitory activity as well as their antiproliferative activities against several human cancer cell lines. The structure-activity relationship study showed that indenopyridines with hydroxyl group at meta or para positions of 2- or 4-phenyl ring displayed selective and significant topoisomerase IIα (topo IIα) inhibitory activity and potent antiproliferative activity. Positive correlation between topo IIα inhibition and antiproliferative activity was observed for compounds 15, 16, 18-20, 22, 23, 25 and 26. The mode of action of compound 16 was further evaluated to be a non-intercalative topo IIα catalytic inhibitor.
为了开发新型抗癌药物,我们设计并合成了羟基化的2,4-二苯基茚并吡啶,并评估了它们对拓扑异构酶的抑制活性以及对几种人类癌细胞系的抗增殖活性。构效关系研究表明,在2-或4-苯环的间位或对位带有羟基的茚并吡啶表现出选择性且显著的拓扑异构酶IIα(topo IIα)抑制活性和强大的抗增殖活性。对于化合物15、16、18 - 20、22、23、25和26,观察到topo IIα抑制与抗增殖活性之间存在正相关。进一步评估化合物16的作用模式为非嵌入性topo IIα催化抑制剂。